medigraphic.com
ENGLISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2018, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2018; 17 (4)


Occult Hepatitis B and Other Unexplored Risk Factors for Hepatocellular Carcinoma in Latin America

Roman S
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 11
Paginas: 541-543
Archivo PDF: 108.56 Kb.


PALABRAS CLAVE

Sin palabras Clave

RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Saffioti F, Raimondo G. What do we know about hepatitis B virus infection? In: AMPM (Atti della Accademia Peloritana dei Pericolaanti-Classe di Scienze Medico-Biologiche). Vol. 105(2): SD2, 2017, p 1-13. DOI:10.6092/1828-6550/ APMB.105.2.2017.SD2.

  2. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-7.

  3. Allain JP. Global epidemiology of occult HBV infection. Ann Blood 2017; 2: 7.

  4. Muto J, Sugiyama M, Shirabe K, Mukaide M, Kirikae-Muto I, Ikegami T, Yoshizumi T, et al. Frequency and characteristics of occult Hepatitis B infection among hepatocellular carcinoma patients in Japan. Annals Hepatol 2018; 17: 596-603.

  5. FH Pujol, Roman S, Panduro A, Navas MC, Lampe E. Hepatocellular Carcinoma in Latin America. In: Chemin I (Ed.). Hepatocellular Carcinoma: A Global Challenge. New York: Nova Science Publishers Inc; 2012, p. 55-68.

  6. Morales-Romero J, Vargas G, García-Román R. Occult HBV Infection: A faceless enemy in liver cancer development. Viruses 2014; 6: 1590-611.

  7. Roman S, Jose-Abrego J, Fierro NA, Escobedo-Melendez G, Ojeda-Granados C, Martinez-Lopez E, Panduro A. Hepatitis B virus infection in Latin America: A genomic medicine approach. World J Gastroenterol 2014: 20: 7181-96.

  8. Panduro A, Maldonado-Gonzalez M, Fierro NA, Roman S. Distribution of HBV genotypes F and H in Mexico and Central America. Antivir Ther 2013; 18: 475-84.

  9. Roman S, Fierro NA, Moreno-Luna LE, Panduro A. Hepatitis B virus genotype H and environmental factors associated to the low prevalence of hepatocellular carcinoma in Mexico. J Cancer Ther 2013; 4: 367-76.

  10. de Gomes SA, Araujo NA, Flichman D, Campos R, Panduro A. Hepatitis B viruses. In: Ludert JE, Pujol FH, Arbiza J (Eds.). Human Virology in Latin America. From Biology to Control. Switzerland, Springer: 2017; p. 309-31.

  11. Jose-Abrego A, Panduro A, Fierro NA, Roman S. High prevalence of HBV infection, detection of subgenotypes F1b, A2, and D4, and differential risk factors among Mexican risk populations with low socioeconomic status. J Med Virol 2017; 89: 2149-57.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2018;17

ARTíCULOS SIMILARES

CARGANDO ...